James Polli

SOP Talent Competition Highlights Student Innovation in Regulatory Science

February 6, 2014

M-CERSI’s “America’s Got Regulatory Science Talent” judges award student first prize for new technology to combat worldwide counterfeit drug crisis.

New MS in Regulatory Science Program Welcomes Inaugural Class

February 4, 2014

New part-time, online graduate program designed for working professionals focuses on drug product development and regulation.

School of Pharmacy Hosts Second Annual M-CERSI Day

September 13, 2013

Forum brings together FDA scientists, the University of Maryland community, and members of the public to discuss current issues in regulatory science and ongoing M-CERSI research, training, and exchange activities.

SOP Faculty Testify During FDA Generic Drug Regulation Public Meeting

July 3, 2013

Drs. Hoag and Polli examine current regulatory science initiatives aimed at generic drugs and discuss ways in which existing initiatives can be improved.

School of Pharmacy Launches New Regulatory Science Graduate Program

March 11, 2013

Available exclusively online, the new MS in Regulatory Science program prepares students to meet the increasing demand for skilled regulatory scientists in academia, government, and industry.

Student Talent Competition Focuses on Improvements in Regulatory Science

February 5, 2013

“America’s Got Regulatory Science Talent” judges award student first prize for his guidelines to improve reporting of adverse medication events to the Food and Drug Administration.

2012-2013 UM-CERSI Awards Announced

December 7, 2012

The University of Maryland Center of Excellence in Regulatory Science and Innovation (UM-CERSI) recently awarded two Innovation Awards and two Innovations in Minority Health Awards to recognize pioneering research initiatives in regulatory science.

Industry, FDA Call for Strides in Regulatory Science at UM Center Launch

September 14, 2012

Center of Excellence in Regulatory Science and Innovation taps researchers at Baltimore and College Park campuses, Food and Drug Administration, and industry to make a difference.

UM-CERSI Awards Inaugural Innovation Awards

March 21, 2012

Funded projects are collaborations between faculty in Baltimore, College Park, and staff at the FDA

SOP Teams With College Park on FDA Drug Regulatory Science Initiative

November 3, 2011

The University of Maryland has assembled an interprofessional team of research scientists from its campuses in Baltimore and College Park for a center of excellence.

Contract to School of Pharmacy to Compare Generic and Brand Epilepsy Pills

October 4, 2010

$1.1 million, two-year contract will study the “switchability” of anti-epileptic drugs and address safety and effectiveness concerns

James E. Polli, PhD, RPh, Named Shangraw/Noxell Endowed Chair

November 17, 2008

Researcher focuses on drug transporters, enhancing drug bioavailability, and problems with drug distribution mechanisms